Clinical Trial Update: Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing inhaled mannitol to rhDNase (dornase alfa) in children with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Bronchitol (mannitol)
• Pulmozyme (dornase alfa)

Snippet

Sponsor: Syntara | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED